Close Menu

NEW YORK – BC Platforms said Tuesday that it has entered into a collaboration with Japanese research institute Riken and the Finnish Institute for Health and Welfare (known by Finnish acronym THL) to build a predictive model to identify people's risk for contracting COVID-19.

The organizations will work together to apply artificial intelligence in an effort to understand genomic and phenotypic associations with the infectious disease. They will seek to determine why and how the SARS-CoV-2 coronavirus is deadly for some patients and not others.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

A survey by Nature finds that most researchers want scientific meetings to continue virtually or with a virtual component, even after the pandemic ends.

Bloomberg reports that the B.1.351 SARS-CoV-2 viral variant could prompt the formulation of better vaccines.

Certain blood proteins may be able to distinguish COVID-19 patients who will become critically ill from those who will not, the Atlanta Journal-Constitution reports.

In Genome Biology this week: algorithm to assess regulatory features, approach to integrate multiple single-cell RNA-seq datasets, and more.